Reimbursement for cancer drugs drops to 85% of AWP

Washington--The new Medicare reform bill, which for the first time providesa prescription drug benefit for Medicare recipients, comes with a hiddencost for physicians who administer chemotherapy drugs in their offices-andperhaps their patients.

Related Content:

Drug TherapyPractice Management

Urology Times Money Matters: Alternative Investments

What can be learned from CMS data on health care spending?

FDA finalizes blueprint for cancer drug trials involving patients with CNS metastases